Jonathan Skelly - 17 Mar 2026 Form 3 Insider Report for James Hardie Industries plc (JHX)

Role
Pres. James Hardie NA
Signature
/s/ Aoife Rockett, as attorney-in-fact for Jonathan Skelly
Issuer symbol
JHX
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
3
Filing time
17 Mar 2026, 16:07:04 UTC
Previous filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Skelly Jonathan Pres. James Hardie NA 303 E. WACKER DR., STE. 2500, CHICAGO /s/ Aoife Rockett, as attorney-in-fact for Jonathan Skelly 17 Mar 2026 0001814380

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JHX Ordinary shares 313,484 17 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 337,721 $11.23 Direct F2
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 16,336 $16.73 Direct F2
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 5,110 $8.49 Direct F2
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 12,405 $20.12 Direct F2
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 49,982 $9.85 Direct F3
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 31,420 $18.62 Direct F4
holding JHX Employee Stock Option (Right to Buy) 17 Mar 2026 Ordinary shares 19,340 $26.12 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 126,901 RSUs that vest as follows: 25,188 on December 15, 2026, 15,971 on December 15 2027 and 85,742 on February 8, 2029.
F2 The options were exercisable as of July 1, 2025, when they were assumed by the issuer in connection with its acquisition of The AZEK Company Inc.
F3 The options became exercisable in three equal installments on December 12, 2023, 2024 and 2025.
F4 The options become exercisable in three equal installments on December 15, 2024, 2025 and 2026.
F5 The options become exercisable in three equal installments on December 15, 2025, 2026 and 2027.

Remarks:

Exhibit 24 - Power of Attorney